Abstract
The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy. The Japanese government initiated sweeping reforms targeting regenerative medicine in 2014, accompanied by substantial investment into stem cell research and development. We survey the impact of these developments and discuss how the government is working to accelerate regenerative medicine while ensuring safety and efficacy.
| Original language | English |
|---|---|
| Pages (from-to) | 153-156 |
| Number of pages | 4 |
| Journal | Cell Stem Cell |
| Volume | 22 |
| Issue number | 2 |
| DOIs |
|
| Publication status | Published - 2018 Feb 1 |
ASJC Scopus subject areas
- Molecular Medicine
- Genetics
- Cell Biology
Fingerprint Dive into the research topics of 'Japan Strengthens Regenerative Medicine Oversight'. Together they form a unique fingerprint.
Cite this
Sipp, D., & Okano, H. (2018). Japan Strengthens Regenerative Medicine Oversight. Cell Stem Cell, 22(2), 153-156. https://doi.org/10.1016/j.stem.2018.01.001